Can prostate specific antigen derivatives and pathological parameters predict significant change in expectant management criteria for prostate cancer?

Masood A. Khan, H Ballentine Carter, Jonathan Epstein, Michael C. Miller, Patricia Landis, Patrick W. Walsh, Alan Partin, Robert Veltri

Research output: Contribution to journal › Article › peer-review

65 Scopus citations

Fingerprint

Dive into the research topics of 'Can prostate specific antigen derivatives and pathological parameters predict significant change in expectant management criteria for prostate cancer?'. Together they form a unique fingerprint.

Medicine & Life Sciences